首页> 外文期刊>International Journal of Reproduction, Contraception, Obstetrics and Gynecology >Mifepristone versus intracervical prostaglandin E2 gel for cervical ripening in primigravid patients at term
【24h】

Mifepristone versus intracervical prostaglandin E2 gel for cervical ripening in primigravid patients at term

机译:米非司酮vs前列腺素E2凝胶足月初孕患者宫颈成熟

获取原文
           

摘要

Background: The cervix has to play dual role in human reproduction. During pregnancy, it should remain firm and closed allowing the fetus to grow in utero until functional maturity is attained while during labour it should soften and dilate, allowing the fetus to pass through the birth canal. Objective of present study was to know and compare the effect of oral Mifepristone with intracervical dinoprostone gel for cervical priming prior to induction of labour at term in an unfavorable cervix of primigravida. Methods: This was prospective randomized comparative study. 100 primigravid patients were included, 50 were placed in each group A and B. Tablet Mifepristone 200mg orally was given in group A patients and intracervical dinoprostone gel induction was done in group B patients. Pre induction Bishop’s score was noted at beginning to compare improvement in Bishop’s score after induction. Mode of delivery and induction to delivery interval in both the groups were studied. Results: After induction with Mifepristone 76% women had successful cervical ripening as compared to 56% with dinoprostone. Rate of vaginal delivery was 70% with Mifepristone and 58% with dinoprostone. There was no significant difference in induction to delivery interval between the groups. Ten percent and 2% belonging to mifepristone and dinoprostone group respectively, required NICU admissions. Conclusions: Mifepristone is more effective than dinoprostone for preinduction cervical ripening as it has high success rate of achieving cervical ripening, however there is no significant difference in the vaginal delivery rate and other maternal and fetal outcome.
机译:背景:子宫颈必须在人类生殖中扮演双重角色。在怀孕期间,它应该保持牢固和闭合,以允许胎儿在子宫内生长,直到达到功能成熟为止;而在分娩过程中,它应该软化和扩张,从而允许胎儿通过产道。本研究的目的是了解并比较口服米非司酮与神经上的狄诺前列酮凝胶在足月引产不利的初产子宫颈之前引产子宫颈的效果。方法:这是前瞻性随机比较研究。包括100名原发性重症患者,A组和B组各放置50名。A组患者口服米非司酮200mg片剂,B组患者进行了辛诺前列酮凝胶内诱导。入职前Bishop的分数一开始就被记录下来,以比较入职后Bishop的分数改善情况。研究了两组的分娩方式和对分娩间隔的诱导。结果:米非司酮诱导后,有76%的妇女宫颈成熟成功,而地诺前列酮的成功率为56%。米非司酮的阴道分娩率为70%,地诺前列酮的阴道分娩率为58%。两组间的诱导间隔没有明显差异。米非司酮组和地诺前列酮组分别有10%和2%需要入院。结论:米非司酮比地诺前列酮对诱导前宫颈成熟更有效,因为米非司酮成功实现宫颈成熟的成功率很高,但是在阴道分娩率和其他母婴结局方面没有显着差异。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号